Individual provider · Type 1 NPI
Shivani Patel, PharmD
Infectious Diseases Pharmacist · Grove City, OH
NPI number
1487523015
Active
Practice location
5300 N Meadows Dr
Grove City, OH 43123-2546
Mailing address
1110 Lusso Ave Unit 201
Columbus, OH 43201-7864
Specialties and licenses
| Taxonomy | Code | License |
|---|---|---|
| Infectious Diseases Pharmacist Primary | 1835I0206X | 03444652 (OH) |
Infectious Diseases Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in the use of microbiology and pharmacology to develop, implement, and monitor drug regimens that incorporate antimicrobials to optimize therapy for patients.
122 other providers at this address
- Mount Carmel Health SystemGeneral Acute Care Hospital Grove City, OH NPI 1710067376
- Premier Anesthesia of Ohio LLCAnesthesiology Physician Grove City, OH NPI 1699196022
- Abdullah Ali, DOPsychiatry Physician Grove City, OH NPI 1437844206
- Adrian Babel, M.S., MDStudent in an Organized Health Care Education/Training Program Grove City, OH NPI 1538954946
- Alex AmosCertified Registered Nurse Anesthetist Grove City, OH NPI 1710677521
- Alex Kimutai KemeiInternal Medicine Physician Grove City, OH NPI 1609517978
- Alexandra Abigail Browne, MDStudent in an Organized Health Care Education/Training Program Grove City, OH NPI 1659211076
- Allison Martin, MDStudent in an Organized Health Care Education/Training Program Grove City, OH NPI 1700465416
- Andrew YoungInternal Medicine Physician Grove City, OH NPI 1306226873
- Ashley Gallagher, RPHPharmacist Grove City, OH NPI 1174100754
- Barbara PhillipsFamily Nurse Practitioner Grove City, OH NPI 1245602002
- Benjamin Abraham, MDStudent in an Organized Health Care Education/Training Program Grove City, OH NPI 1265886733
About NPI 1487523015
Shivani Patel, PharmD's National Provider Identifier is 1487523015, issued on Nov 3, 2025. The primary taxonomy on file is Infectious Diseases Pharmacist (1835I0206X), and the practice location is in Grove City, OH. The record was last updated on Nov 3, 2025.